{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:35:47Z","timestamp":1780580147977,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.beha.2020.101196","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T19:32:23Z","timestamp":1591299143000},"page":"101196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cytogenetics in the genomic era"],"prefix":"10.1016","volume":"33","author":[{"given":"Isabel","family":"Granada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Ruiz-Xivill\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Mallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.beha.2020.101196_bib1","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41375-019-0378-z","article-title":"European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms","volume":"33","author":"Rack","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101196_bib2","series-title":"ISCN2016: an international system for human cytogenetic nomenclature","author":"McGowan-Jordan","year":"2016"},{"key":"10.1016\/j.beha.2020.101196_bib3","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"issue":"2","key":"10.1016\/j.beha.2020.101196_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.leukres.2009.07.006","article-title":"Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: an International Working Group on MDS Cytogenetics Study","volume":"34","author":"Chun","year":"2010","journal-title":"Leuk Res"},{"issue":"9","key":"10.1016\/j.beha.2020.101196_bib5","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.leu.2402605","article-title":"Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype","volume":"16","author":"Cuneo","year":"2002","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.beha.2020.101196_bib6","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/sj.leu.2402293","article-title":"Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype","volume":"15","author":"Rigolin","year":"2001","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.beha.2020.101196_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2353\/jmoldx.2007.060128","article-title":"Guidance for fluorescence in situ hybridization testing in hematologic disorders","volume":"9","author":"Wolff","year":"2007","journal-title":"J Mol Diagn JMD"},{"issue":"1","key":"10.1016\/j.beha.2020.101196_bib8","first-page":"16","article-title":"Preclinical validation of fluorescence in situ hybridization assays for clinical practice","volume":"8","author":"Wiktor","year":"2006","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"9","key":"10.1016\/j.beha.2020.101196_bib9","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.3109\/10428194.2014.1003053","article-title":"Clinical usefulness of fluorescence in situ hybridization for detection of MLL rearrangements in acute myeloid leukemia","volume":"56","author":"Ruiz-Xivill\u00e9","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.beha.2020.101196_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3324\/haematol.2014.112912","article-title":"Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia","volume":"100","author":"Safavi","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.beha.2020.101196_bib11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/10428194.2012.731598","article-title":"Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?","volume":"54","author":"Puiggros","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"27","key":"10.1016\/j.beha.2020.101196_bib12","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1200\/JCO.2008.20.6136","article-title":"Prognostic significance of copy-number alterations in multiple myeloma","volume":"27","author":"Avet-Loiseau","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"10.1016\/j.beha.2020.101196_bib13","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3324\/haematol.2018.204974","article-title":"Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort","volume":"104","author":"Zaliova","year":"2019","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.beha.2020.101196_bib14","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2007-05-092304","article-title":"Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS\/MPD, and MDS-derived AML","volume":"111","author":"Gondek","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2020.101196_bib15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/gcc.22350","article-title":"Guidelines for genomic array analysis in acquired haematological neoplastic disorders","volume":"55","author":"Schoumans","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.beha.2020.101196_bib16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/leu.2015.29","article-title":"Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia","volume":"29","author":"Cross","year":"2015","journal-title":"Leukemia"},{"issue":"22","key":"10.1016\/j.beha.2020.101196_bib17","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/blood-2016-01-690230","article-title":"Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy","volume":"127","author":"Wang","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2020.101196_bib18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.beha.2020.101196_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2141.2005.05593.x","article-title":"Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia","volume":"130","author":"Dingli","year":"2005","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.beha.2020.101196_bib20","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/s41375-018-0107-z","article-title":"GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis","volume":"32","author":"Tefferi","year":"2018","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.beha.2020.101196_bib21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/ajh.25617","article-title":"World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management","volume":"94","author":"Shomali","year":"2019","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.beha.2020.101196_bib22","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1111\/bjh.16340","article-title":"Frequent false-negative FIP1L1-PDGFRA FISH analyses of bone marrow samples from clonal eosinophilia at diagnosis","volume":"188","author":"Olsson-Arvidsson","year":"2020","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.beha.2020.101196_bib23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/bjh.14488","article-title":"Guideline for the investigation and management of eosinophilia","volume":"176","author":"Butt","year":"2017","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.beha.2020.101196_bib24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","article-title":"Myeloid neoplasms with eosinophilia","volume":"129","author":"Reiter","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2020.101196_bib25","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1080\/10428194.2017.1397663","article-title":"Myeloid\/lymphoid neoplasms with FGFR1 rearrangement","volume":"59","author":"Strati","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.beha.2020.101196_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1755-8166-6-39","article-title":"Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review","volume":"6","author":"Gancheva","year":"2013","journal-title":"Mol Cytogenet"},{"issue":"9","key":"10.1016\/j.beha.2020.101196_bib27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3324\/haematol.2016.144345","article-title":"Characterization of leukemias with ETV6-ABL1 fusion","volume":"101","author":"Zaliova","year":"2016","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.beha.2020.101196_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2010.030957","article-title":"Cytogenetic risk stratification in chronic myelomonocytic leukemia","volume":"96","author":"Such","year":"2011","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.beha.2020.101196_bib29","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2016-05-714030","article-title":"Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia","volume":"128","author":"Elena","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2020.101196_bib30","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2020.101196_bib31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2020.101196_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-4608(89)90025-3","article-title":"The clinical significance of karyotype in acute myelogenous leukemia","volume":"40","author":"Arthur","year":"1989","journal-title":"Canc Genet Cytogenet"},{"issue":"13","key":"10.1016\/j.beha.2020.101196_bib33","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2020.101196_bib34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"issue":"29","key":"10.1016\/j.beha.2020.101196_bib35","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1200\/JCO.2008.16.0259","article-title":"Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype","volume":"26","author":"Breems","year":"2008","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.beha.2020.101196_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","article-title":"Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97\/99 randomised trial","volume":"11","author":"Moorman","year":"2010","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.beha.2020.101196_bib37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","article-title":"Genetic basis of acute lymphoblastic leukemia","volume":"35","author":"Iacobucci","year":"2017","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.beha.2020.101196_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3324\/haematol.2015.141101","article-title":"New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia","volume":"101","author":"Moorman","year":"2016","journal-title":"Haematologica"},{"issue":"26","key":"10.1016\/j.beha.2020.101196_bib39","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.beha.2020.101196_bib40","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/sj.leu.2404935","article-title":"Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping","volume":"21","author":"Haferlach","year":"2007","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.beha.2020.101196_bib41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s12185-014-1681-0","article-title":"CpG Oligonucleotide and Interleukin 2 stimulation enables higher cytogenetic abnormality detection rates than 12-o-tetradecanolyphorbol-13-acetate in Asian patients with B-cell chronic lymphocytic leukemia (B-CLL)","volume":"100","author":"Liaw","year":"2014","journal-title":"Int J Hematol"},{"issue":"10","key":"10.1016\/j.beha.2020.101196_bib42","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ajh.24452","article-title":"FISHing in the dark: how the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia","volume":"91","author":"Dubuc","year":"2016","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.beha.2020.101196_bib43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jmoldx.2012.09.006","article-title":"Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes","volume":"15","author":"Schweighofer","year":"2013","journal-title":"J Mol Diagn JMD"},{"issue":"11","key":"10.1016\/j.beha.2020.101196_bib44","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact","volume":"133","author":"Baliakas","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2020.101196_bib45","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.1002\/ajh.24754","article-title":"Monosomal karyotype in chronic lymphocytic leukemia: association with clinical and biological features and potential prognostic significance","volume":"92","author":"Baptista","year":"2017","journal-title":"Am J Hematol"},{"issue":"25","key":"10.1016\/j.beha.2020.101196_bib46","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.beha.2020.101196_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hon.2065","article-title":"Molecular classification and risk stratification of myeloma","volume":"31","author":"Bergsagel","year":"2013","journal-title":"Hematol Oncol"},{"issue":"24","key":"10.1016\/j.beha.2020.101196_bib48","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2016-01-631200","article-title":"Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group","volume":"127","author":"Sonneveld","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2020.101196_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-4608(99)00009-6","article-title":"Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma","volume":"113","author":"Rajkumar","year":"1999","journal-title":"Canc Genet Cytogenet"},{"issue":"19","key":"10.1016\/j.beha.2020.101196_bib50","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1200\/JCO.18.00776","article-title":"Development and validation of a cytogenetic prognostic index predicting survival in multiple myeloma","volume":"37","author":"Perrot","year":"2019","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"26","key":"10.1016\/j.beha.2020.101196_bib51","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from international myeloma working group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"10.1016\/j.beha.2020.101196_bib52","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood-2018-10-880831","article-title":"High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma","volume":"133","author":"Thakurta","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2020.101196_bib53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbmt.2019.12.726","article-title":"Outcome of multiple myeloma with chromosome 1q gain and 1p deletion after autologous hematopoietic stem cell transplantation: propensity-score matched analysis: outcome of 1q+\/1p- MM pts after auto-HCT","volume":"26","author":"Varma","year":"2020","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.beha.2020.101196_bib54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41408-019-0226-4","article-title":"An acquired high-risk chromosome instability phenotype in multiple myeloma: jumping 1q Syndrome","volume":"9","author":"Sawyer","year":"2019","journal-title":"Blood Canc J"},{"issue":"22","key":"10.1016\/j.beha.2020.101196_bib55","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2017-06-788786","article-title":"Efficacy of venetoclax as targeted therapy for relapsed\/refractory t(11;14) multiple myeloma","volume":"130","author":"Kumar","year":"2017","journal-title":"Blood"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692620300578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692620300578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:05:28Z","timestamp":1761498328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692620300578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1521692620300578"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2020.101196","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetics in the genomic era","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2020.101196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101196"}}